title: Value-based Health Care: One Patient's Experience and What Really Matters.
abstract: Meet Jonathan Friedlaender, a cancer survivor whose 20-year-long struggle helps illustrate drug pricing's important role in this arena.
authors.forename: Thomas
authors.initials: T
authors.lastname: Reinke
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003657:Decision Making; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D018802:Patient-Centered Care; D010817:Physician-Patient Relations; D017741:Survivors; D014481:United States
chemical_list: D000970:Antineoplastic Agents